Drug class
Immunomodulatory antiviral agent; inosine pranobex complex
Mechanism of action
The exact mechanism is not fully established. It appears to modulate cell-mediated immune responses, including T-cell differentiation and lymphoproliferative responses, rather than acting directly on viral enzymes.
General use cases
- Adjunctive treatment of selected viral infections in countries where inosine pranobex is authorised; exact indications vary by product and jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
